- Home
- HLIO vs DAWN Comparison
HLIO vs DAWN Comparison
Compare HLIO & DAWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLIO
- DAWN
- Stock Information
- Founded
- HLIO 1970
- DAWN 2018
- Country
- HLIO United States
- DAWN United States
- Employees
- HLIO N/A
- DAWN N/A
- Industry
- HLIO Metal Fabrications
- DAWN Biotechnology: Pharmaceutical Preparations
- Sector
- HLIO Industrials
- DAWN Health Care
- Exchange
- HLIO Nasdaq
- DAWN Nasdaq
- Market Cap
- HLIO 1.4B
- DAWN 1.2B
- IPO Year
- HLIO N/A
- DAWN 2021
- Fundamental
- Price
- HLIO $32.26
- DAWN $8.07
- Analyst Decision
- HLIO Buy
- DAWN Strong Buy
- Analyst Count
- HLIO 2
- DAWN 7
- Target Price
- HLIO $58.00
- DAWN $32.29
- AVG Volume (30 Days)
- HLIO 204.0K
- DAWN 1.3M
- Earning Date
- HLIO 05-07-2025
- DAWN 05-05-2025
- Dividend Yield
- HLIO 1.06%
- DAWN N/A
- EPS Growth
- HLIO 2.65
- DAWN N/A
- EPS
- HLIO 1.17
- DAWN N/A
- Revenue
- HLIO $805,900,000.00
- DAWN $131,161,000.00
- Revenue This Year
- HLIO $1.26
- DAWN $28.72
- Revenue Next Year
- HLIO $5.89
- DAWN $73.78
- P/E Ratio
- HLIO $29.09
- DAWN N/A
- Revenue Growth
- HLIO N/A
- DAWN N/A
- 52 Week Low
- HLIO $32.10
- DAWN $7.88
- 52 Week High
- HLIO $57.29
- DAWN $18.07
- Technical
- Relative Strength Index (RSI)
- HLIO 26.37
- DAWN 36.05
- Support Level
- HLIO $33.10
- DAWN $7.93
- Resistance Level
- HLIO $35.03
- DAWN $8.44
- Average True Range (ATR)
- HLIO 1.25
- DAWN 0.44
- MACD
- HLIO -0.03
- DAWN 0.09
- Stochastic Oscillator
- HLIO 3.05
- DAWN 17.59
About HLIO Helios Technologies Inc.
Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness.
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.